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Background and aims: Blood tests and liver stiffness evaluation (LSE) by
ultrasonographic elastometry are accurate tools for diagnosing liver fibrosis. We
evaluated whether their synchronous combination in new scores could improve the
diagnostic accuracy and reduce liver biopsy requirement in algorithm. Methods:
Three hundred and ninety patients with chronic liver disease of miscellaneous causes
were included. Five blood fibrosis tests were evaluated: APRI, FIB-4, Hepascore,
Fibrotest and FibroMeter. The reference was fibrosis Metavir staging. Results:
Diagnosis of significant fibrosis (Metavir F≥2). The most accurate synchronous
combination was FibroMeter+LSE, which provided a significantly higher area under
the receiver operating characteristic curve (0.892) than LSE alone (0.867, P=0.011)
or Fibrometer (0.834, P<10−3). An algorithm using the FibroMeter+LSE
combination and then a liver biopsy in indeterminate cases had 91.9% diagnostic
accuracy and required significantly fewer biopsies (20.2%) than previously published
Bordeaux algorithm (28.6%, P=0.02) or sequential algorithm for fibrosis evaluation
(SAFE) (55.7%, P<10−3). The Angers algorithm performance was not significantly
different between viral hepatitis and other causes. Diagnosis of cirrhosis. The most
accurate synchronous combination was LSE+FibroMeter, which provided ≥90%
predictive values for cirrhosis in 90.6% of patients vs 87.4% for LSE (P=0.02) and
57.9% for FibroMeter (P<10−3). An algorithm including the LSE+FibroMeter
combination, and then a liver biopsy in indeterminate cases, had a significantly
higher diagnostic accuracy than the SAFE algorithm (91.0 vs 79.8%, P<10−3), and
required significantly fewer biopsies than the Bordeaux algorithm (9.3 vs 25.3%,
P<10−3). Conclusion: The synchronous combination of a blood test plus LSE
improves the accuracy of the non-invasive diagnosis of liver fibrosis and,
consequently, markedly decreases the biopsy requirement in the diagnostic
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